Geron's Stem Cell Program Sold
Scientist (blog) - 2 hours ago
Scientist (blog) - 2 hours ago
The deal, announced yesterday (October 1), is “a complex stock-swapping and intellectual property deal, including a new subsidiary called Asterias Biotherapeutics Inc.,†reported the San Francisco Business Times, but in the end, BioTime has acquired ...
View the full article